NCT04921306View on ClinicalTrials.gov

Obese Human Beta-2-adrenergic Stimulation and Muscle Glucose Uptake

PHASE2CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

August 16, 2022

Primary Completion Date

March 1, 2024

Study Completion Date

March 1, 2024

Conditions
Type 2 Diabetes
Interventions
DRUG

Clenbuterol Hydrochloride

Daily ingestion of clenbuterol hydrochloride capsules (40 microgram/day) for a total period of 28 days with a wash-out period of at least 6-8 weeks.

DRUG

Placebo

Daily ingestion of placebo capsules for a total period of 28 days with a wash-out period of at least 6-8 weeks.

Trial Locations (1)

Unknown

Maastricht University, Maastricht

Sponsors

Collaborators (1)

Eurostars
All Listed Sponsors
collaborator

Eurostars

OTHER

lead

Maastricht University

OTHER

NCT04921306 - Obese Human Beta-2-adrenergic Stimulation and Muscle Glucose Uptake | Biotech Hunter | Biotech Hunter